Methscopolamine Bromide
NDC 51991-191, methscopolamine bromide, tablet, from Breckenridge Pharmaceutical, Inc..
- Product NDC
- 51991-191
- Status
- Listed
- Labeler
- Breckenridge Pharmaceutical, Inc.
- Dosage form
- TABLET
- Route
- ORAL
- Product type
- HUMAN PRESCRIPTION DRUG
- Marketing category
- ANDA
- Application
- ANDA040642
- DEA schedule
- None
curl https://api.healthcare.dev/v1/drugs/ndc/51991-191 \ -H "Authorization: Bearer $HDEV_API_KEY"
Product
Active ingredients and packages
Active ingredients
- METHSCOPOLAMINE BROMIDE2.5 mg/1
Pharmacologic classes
Anticholinergic [EPC]; Cholinergic Antagonists [MoA]
| Package NDC | NDC-11 | Package |
|---|---|---|
| 51991-191-01 | 51991019101 | 100 TABLET in 1 BOTTLE (51991-191-01) |
Linked data
RxNorm, label and prices
RxNorm concepts
Related lookups
FDA label sections
GET /v1/drugs/labels/157c1cce-bceb-4c74-8aa0-d2be9952d8f9NADAC price for package 51991019101
GET /v1/drugs/nadac/51991019101
Use it
Look up 51991-191 from code or an agent
curl https://api.healthcare.dev/v1/drugs/ndc/51991-191 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up NDC 51991-191. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.
Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.